COVID‑19 Vaccination and Usefulness in Prevention of Mortality Among the Elderly: An Analysis

Beuy Joob, Viroj Wiwanitkit


Dear editor, COVID‑19 is the new vaccine that becomes the hope for COVID‑19 containment at present. Since COVID‑19 pandemic is still the worldwide problem, the newly available vaccine is urgently registered and used in many countries. The main consideration is on the efficacy and safety of the new vaccine. Although there are some reports on COVID‑19 vaccine clinical trials, the data are from studies among healthy adult subjects.


COVID‑19; Vaccination; Prevention; Mortality; Elderly

Full Text:



Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX,

et al. Safety, tolerability, and immunogenicity of a

recombinant adenovirus type‑5 vectored COVID‑19 vaccine:

A dose‑escalation, open‑label, non‑randomised, first‑in‑human

trial. Lancet 2020;395:1845‑54.

Palacios R, Patiño EG, de Oliveira Piorelli R, Conde MTRP,

Batista AP, Zeng G, et al. Double‑blind, randomized,

placebo‑controlled phase III clinical trial to evaluate the efficacy

and safety of treating healthcare professionals with the adsorbed

COVID‑19 (Inactivated) vaccine manufactured by sinovac ‑

PROFISCOV: A structured summary of a study protocol for a

randomised controlled trial. Trials 2020;21:853.

Wiwanitkit V. COVID‑19, vaccine, safety, adverse effect and

death. Available from:

n149/rr‑11.[Last accessed on 2021 Jan 20].

Knoll MD, Wonodi C. Oxford‑AstraZeneca COVID‑19 vaccine efficacy. Lancet 2021;397:72‑4.

Lipsitch M, Dean NE. Understanding COVID‑19 vaccine

efficacy. Science 2020;370:763‑5.

Shahid Z, Kalayanamitra R, McClafferty B, Kepko D,

Ramgobin D, Patel R, et al. COVID‑19 and older adults: What

we know. J Am Geriatr Soc 2020;68:926‑9.

Kang SJ, Jung SI. Age‑related morbidity and mortality among

patients with COVID‑19. Infect Chemother 2020;52:154‑64.

Torjesen I. Covid‑19: Norway investigates 23 deaths in frail

elderly patients after vaccination. BMJ 2021;372:149.